Autopsy report · NCT02506127
Intermittent Theta Burst Stimulation for MDD
Cause of deathFutility
“Protocol discontinued for futility”
Life of this trial
- Registered 2 years 5 months before it started.
- Suspended: paused, and may or may not restart.
- 30 participants planned (an estimate, not an actual count).
Vital statistics
- Status
- Suspended
- Phase
- Na
- Sponsor
- University of California, Los Angeles
- Sponsor type
- University, hospital or other
- Conditions
- Major Depressive Disorder
- Interventions
- Neuronetics XPLOR system
- Participants
- 30 (planned, not actual)
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Dose Escalation and Dose Expansion Study of GSK525762 in Combination With Androgen Deprivation Therapy in Participants With Castrate-resistant Prostate Cancer
“This study has been terminated due to meeting protocol defined futility.” - An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
“Protocol was cancelled by company based on overall efficacy, no safety concern” - RCT for Women With a Persisting Pregnancy of Unknown Location
“A new protocol was written to replace this protocol.” - Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant
“Replaced by another protocol” - Ibrutinib and Ixazomib Citrate in Treating Newly Diagnosed, Relapsed or Refractory Waldenstrom Macroglobulinemia
“Discontinued after interim analysis for futility; no treatment successes observed in the first 12 patients”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.